D.C. Week: $6 Trillion Healthcare Projection; FDA Criticism, Warning


FDA failed to react to evidence that fentanyl products were inappropriately prescribed

by Shannon Firth, Washington Correspondent, MedPage Today

WASHINGTON — Hefty new annual projections on healthcare spending emerge from the Center for Medicare; Medicaid Services (CMS), and the FDA takes heat over its handling of a fentanyl Risk Evaluation and Mitigation Strategy (REMS) program and warns on unproven young plasma infusion therapies.

CMS: Flood of Baby Boomers to Drive Growth in U.S. Health Spending

Carol graduated from Riverside White Cross School of Nursing in Columbus, Ohio and received her diploma as a registered nurse. She attended Bowling Green State University where she received a Bachelor of Arts Degree in History and Literature. She attended the University of Toledo, College of Nursing, and received a Master’s of Nursing Science Degree as an Educator.

She has traveled extensively, is a photographer, and writes on medical issues. Carol has three children RJ, Katherine, and Stephen – two daughters-in-law; Suzy and Katie – two granddaughters; Isabella Marianna and Zoe Olivia – and one grandson, Alexander Paul. She also shares her life with husband Gordon Duff, many cats, two rescue pups, and two guinea pigs.

Carol’s Archives 2009-2013
DISCLOSURES: All content herein is owned by author exclusively.  Expressed opinions are NOT necessarily the views of VT, authors, affiliates, advertisers, sponsors, partners or technicians. Some content may be satirical in nature. All images within are full responsibility of author and NOT VT.

About VT - Read Full Policy Notice - Comment Policy